1 min read
Ginkgo Bioworks Posts $27.7 Million in Q3 Revenue, Reaffirms 2026 Cash-Burn Outlook
The company recorded a $0.64 GAAP loss per share, $0.22 better than estimates, while revenue exceeded estimates by $6.19 million.

Ginkgo Bioworks Holdings, Inc. posted third-quarter revenue of $27.7 million, down 5.7% from a year earlier, and reaffirmed its full-year 2026 outlook for total cash burn of $125 million to $150 million.
GAAP loss per share was $0.64, $0.22 better than estimates. Revenue exceeded estimates by $6.19 million.